Matters arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease

Saved in:
Bibliographic Details
Published in:NPJ Parkinson's Disease 2024-03, Vol.10 (1), p.59-59, Article 59
Main Author: Steiner, Michel Alexander
Format: Article
Language:English
Subjects:
631/154/436
631/378/1689
631/443/376
692/617/375
692/699/476
Biomedical and Life Sciences
Biomedicine
Matters Arising
Neurology
Neurosciences
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2373-8057
2373-8057
DOI:10.1038/s41531-024-00657-7